NAM Leadership Consortium Members and Biographies

Mark McClellan, MD, PhD - Chair

Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. With offices in Durham, NC and Washington, DC, the Center is a university-wide Duke initiative that is quickly becoming nationally and internationally-recognized research, evaluation, implementation, and educational initiatives to improve health policy and health. It integrates Duke’s expertise in the social, clinical, and analytical sciences alongside engagement with health care leaders and stakeholders, to develop and apply policy solutions that improve health and the value of health care locally, nationally, and worldwide.

Dr. McClellan is a doctor and an economist whose has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. He also has a highly distinguished record in public service and academic research.

Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.

Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA, is a member of the National Academy of Medicine. At NAM, he chairs the Leadership Council for Value and Science-Driven Health care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He is also a Senior Advisor on the faculty of the University of Texas Dell Medical School and is an independent director on the board of Johnson & Johnson and on the board of Alignment Healthcare. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.

Amy Abernethy, MD, PhD

Amy P. Abernethy, MD PhD is a hematologist/oncologist and palliative medicine physician, and an internationally recognized clinical data expert and clinical researcher. With over 500 publications, Dr. Abernethy is an expert in real-world data & evidence, clinical trials, patient-reported outcomes, clinical informatics, and patient-centered care. She is currently the President of Verily’s Clinical Studies Platforms, where she oversees the company’s clinical evidence generation platform product vision and related clinical research portfolio. She was most recently the Principal Deputy Commissioner and Acting Chief Information Officer of the US Food & Drug Administration, serving from February 2019 to April 2021. Dr. Abernethy initiated multiple critical efforts during her tenure including FDA’s technology and data modernization action plans and FDA’s efforts to leverage real-world data & evidence to address critical questions during the pandemic.

Dr. Abernethy was Chief Medical Officer and Chief Scientific Officer at Flatiron Health from July 2014 to January 2019. Before joining Flatiron, Dr. Abernethy was Professor of Medicine at Duke University School of Medicine and directed the Center for Learning Health Care in the Duke Clinical Research Institute and Duke Cancer Care Research Program in the Duke Cancer Institute. For more than 15 years, she pioneered the development of technology platforms to spur novel advancements in cancer care, including the development of systems by which linked clinical data can support tracking cancer care, drug development, personalized medicine and scientific discovery. She also previously served as an appointee to the National Academy of Medicine’s (formerly the Institute of Medicine) National Cancer Policy Forum, on the Board of the Personalized Medicine Coalition, and President of the American Academy of Hospice & Palliative Medicine.

Dr. Abernethy went to the University of Pennsylvania as an undergraduate, and then medical school at Duke, where she also did her Internal Medicine residency, a year as Chief Resident, and her hematology/oncology fellowship. She has her PhD from Flinders University in Australia, focused on evidence-based medicine.

Shantanu Agrawal, MD, MPhil

Shantanu Agrawal is the Chief Health Officer of Anthem, Inc. Dr. Agrawal oversees Anthem’s enterprise health strategy, to include medical policy and clinical quality, as well as the company’s industry-leading work to address the social drivers of health. He will also lead Anthem’s community health strategy and the Anthem Foundation. 

Dr. Agrawal most recently served as President and Chief Executive Officer of the National Quality Forum (NQF), a non-profit organization dedicated to working with members of the healthcare community to drive measurable health improvements. He is also the former Deputy Administrator for the Centers for Medicare & Medicaid Services (CMS), where he led an effort to improve the physician experience with Medicare and was also was one of the main architects of CMS’s strategy to address the national opioid epidemic. Dr. Agrawal also served as Director of the Center for Program Integrity (CPI), where he was instrumental in launching new initiatives in data transparency and analytics, utilization management and payment models.

Dr. Agrawal serves on the board of the Grameen Foundation and the Presidential Advisory Council of Brown University’s School of Public Health. He is also Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania and Associate Clinical Professor of Emergency Medicine at the George Washington University School of Medicine.

Dr. Agrawal completed his undergraduate education at Brown University, medical education at Weill Medical College of Cornell University, and clinical training in Emergency Medicine at the Hospital of the University of Pennsylvania. He earned his master’s degree in Social and Political Sciences from Cambridge University.

Jeffrey R. Balser, MD, PhD

Dr. Balser undertook residency training in anesthesiology and fellowship training in cardiac anesthesiology and in critical care medicine at The Johns Hopkins Hospital in Baltimore, MD. He joined the faculty at Johns Hopkins in 1995, where he practiced cardiac anesthesiology, ICU medicine, and led an NIH-funded research program aimed at the genetics of cardiac rhythm disorders, such as sudden cardiac death.

He returned to Vanderbilt in 1998 as Associate Dean for Physician Scientist Development, and soon was appointed Chair of the Department of Anesthesiology, directing one of the medical center’s largest clinical service programs. He became the Medical Center’s chief research officer in 2004, leading a period of scientific expansion that moved the Medical Center into the nation’s top 10 in NIH funding, launching big-science programs integrating health informatics and genomics that stimulated the Medical Center’s national leadership in personalized medicine.

In 2008 he was elected to the National Academy of Medicine, and later that year was named the eleventh dean of Vanderbilt’s School of Medicine since its founding in 1875. In 2009, he was also named Vice Chancellor for Health Affairs with executive responsibility for all health-related programs including the hospitals, clinics, research programs, and the medical and nursing schools. He has led the Medical Center through a period of marked service-volume growth with major inpatient expansions of the children’s hospital and the adult critical care areas, bolstered by 4% compound annual growth of outpatient visits (over 2.1 million per year), and by the creation of region’s largest, multi-state provider-led network (over 50 hospitals and 3000 clinicians: the Vanderbilt Health Affiliated Network).

In 2013-2014, he led a $230 million (8%) cost reduction across all mission areas, improving the Medical Center’s competitive position in a rapidly evolving price-sensitive marketplace. In coordination with the Vanderbilt Chancellor and Board of Trust, Dr. Balser has led the Medical Center through a restructuring process that concluded April 30, 2016, placing its clinicians, hospitals, clinics, research and graduate medical education programs into a financially distinct not-for-profit corporation, Vanderbilt University Medical Center (VUMC). As President and CEO of VUMC, he reports to an independent board of directors, while also serving as dean of the Vanderbilt University School of Medicine.

Georges C. Benjamin, MD

Georges Benjamin, MD, is known as one of the nation’s most influential physician leaders because he speaks passionately and eloquently about the health issues having the most impact on our nation today. From his firsthand experience as a physician, he knows what happens when preventive care is not available and when the healthy choice is not the easy choice. As executive director of APHA since 2002, he is leading the Association’s push to make America the healthiest nation in one generation. He came to APHA from his position as secretary of the Maryland Department of Health and Mental Hygiene. Benjamin became secretary of health in Maryland in April 1999, following four years as its deputy secretary for public health services. As secretary, Benjamin oversaw the expansion and improvement of the state’s Medicaid program.

Benjamin, of Gaithersburg, Maryland, is a graduate of the Illinois Institute of Technology and the University of Illinois College of Medicine. He is board-certified in internal medicine and a fellow of the American College of Physicians, a fellow of the National Academy of Public Administration, a fellow emeritus of the American College of Emergency Physicians and an honorary fellow of the Royal Society of Public Health.

An established administrator, author and orator, Benjamin started his medical career in 1981 in Tacoma, Washington, where he managed a 72,000-patient visit ambulatory care service as chief of the Acute Illness Clinic at the Madigan Army Medical Center and was an attending physician within the Department of Emergency Medicine. A few years later, he moved to Washington, D.C., where he served as chief of emergency medicine at the Walter Reed Army Medical Center. After leaving the Army, he chaired the Department of Community Health and Ambulatory Care at the District of Columbia General Hospital. He was promoted to acting commissioner for public health for the District of Columbia and later directed one of the busiest ambulance services in the nation as interim director of the Emergency Ambulance Bureau of the District of Columbia Fire Department.

At APHA, Benjamin also serves as publisher of the nonprofit’s monthly publication, The Nation’s Health, the association’s official newspaper, and the American Journal of Public Health, the profession’s premier scientific publication. He is the author of more than 100 scientific articles and book chapters. His recent book The Quest for Health Reform: A Satirical History is an exposé of the nearly 100-year quest to ensure quality affordable health coverage for all through the use of political cartoons.

Benjamin is a member of the National Academy of Medicine (Formally the Institute of Medicine) of the National Academies of Science, Engineering and Medicine and also serves on the boards for many organizations including Research!America and the Reagan-Udall Foundation. In 2008, 2014 and 2016 he was named one of the top 25 minority executives in health care by Modern Healthcare Magazine, in addition to being voted among the 100 most influential people in health care from 2007-2017.

In April 2016, President Obama appointed Benjamin to the National Infrastructure Advisory Council, a council that advises the president on how best to assure the security of the nation’s critical infrastructure.

Rachele Berria, MD, PhD

Rachele Berria, MD, PhD, leads the US Medical Team at AstraZeneca, ensuring scientific leadership and a patient-centered approach throughout the Organization. She is a member of the US Leadership Team and the Global Biopharmaceuticals Medical Leadership Team.

Dr. Berria brings over ten years of global and US biopharmaceuticals experience and leadership, in addition to her experiences in clinical research and academic medicine. Most recently, she worked at Sanofi as Global VP, Medical Affairs, Primary Care Unit. Prior to that, she held roles as US Vice President, Diabetes Medical Unit, and Global Associate VP, Medical Affairs. Before Sanofi, she held roles at Roche-Genentech as US Medical Director, Cardio-Metabolism, and Associate Clinical Director, Global R&D.

Dr. Berria received her medical degree at the University of Cagliari School of Medicine, Italy and a PhD in Medical Pathophysiology and Pharmacology at the University of Pisa School of Medicine, Italy. 

David Blumenthal, MD, MPP

David Blumenthal, MD, MPP, became President and CEO of the Commonwealth Fund, a national health care philanthropy based in New York City, in January, 2013. Previously, he served as Chief Health Information and Innovation Officer at Partners Health System in Boston, MA, and was Samuel O. Thier Professor of Medicine and Professor of Health Care Policy at Massachusetts General Hospital/ Harvard Medical School. From 2009 to 2011, Dr. Blumenthal was the National Coordinator for Health Information Technology under President Barack Obama. In this role he was charged with building an interoperable, private and secure nationwide health information system and supporting the widespread, meaningful use of health IT. Prior to that, Dr. Blumenthal was a practicing primary care physician, director of the Institute for Health Policy, and professor of medicine and health policy at Massachusetts General Hospital/Partners Healthcare System and Harvard Medical School. As a renowned health services researcher and national authority on health IT adoption, Dr. Blumenthal has authored over 250 scholarly publications, including the seminal studies on the adoption and use of health information technology in the United States. Dr. Blumenthal received his undergraduate, medical, and public policy degrees from Harvard University and completed his residency in internal medicine at Massachusetts General Hospital.

Nakela L. Cook, MD, MPH

Nakela L. Cook, MD, MPH, is Executive Director at the Patient-Centered Outcomes Research Institute (PCORI). She is a cardiologist and health services researcher with a distinguished career leading key scientific initiatives engaging patients, clinicians, and other healthcare stakeholders at one of the nation’s largest public health research funders.

Cook leads PCORI’s research, dissemination and implementation, and engagement work as the organization enters its second decade of service to the nation. She also provides strategic and day-to-day oversight of ongoing programs as well as new initiatives designed to create a healthcare system that is more efficient, effective, and patient-centered.

Prior to her current role, Cook served as Senior Scientific Officer and Chief of Staff at the National Heart, Lung, and Blood Institute (NHLBI), the third-largest institute of the National Institutes of Health, with a staff of 1,000 and an annual budget of over $3 billion. There she spearheaded the development and implementation of NHLBI’s strategic plan and initiatives in precision medicine, data science, sickle cell disease, and women’s health with meaningful engagement of stakeholder groups.

Preceding her position as Chief of Staff, Cook was a Clinical Medical Officer in NHLBI’s Division of Cardiovascular Sciences and an attending cardiologist at the Washington Hospital Center in Washington, D.C. She has a bachelor of science degree in materials science and engineering from the University of Alabama at Birmingham; earned her medical degree and master of public health in health care policy and management from Harvard Medical School and Harvard School of Public Health, respectively; and completed her clinical training at Massachusetts General Hospital in Boston. Cook is also an alumna of the Commonwealth Fund/Harvard University Fellowship in Minority Health Policy.

Throughout her career, Cook has worked to enhance diversity and equity in research and care delivery and been a leader in efforts to reduce disparities in health access and outcomes. She has received numerous awards for her excellence in clinical teaching and mentorship as well as her leadership of complex scientific initiatives and programs.

Karen DeSalvo, MD, MPH, MSc

Karen B. DeSalvo, MD, MPH, MSc is Chief Health Officer at Google Health. She is also adjunct Professor of Medicine and Population Health at University of Texas at Austin Dell Medical School and co-convenes the National Alliance to Impact the Social Determinants of Health.  She is a physician executive working at the intersection of medicine, public health, and information technology to improve the health of all people with a focus on catalyzing pragmatic solutions to address all the social determinants of health.  Dr. DeSalvo was National Coordinator for Health Information Technology and Assistant Secretary for Health (Acting) in the Obama Administration.  Prior to joining HHS, she was the New Orleans Health Commissioner.  Dr. DeSalvo was previously Vice Dean for Community Affairs and Health Policy at Tulane School of Medicine, Chief of General Internal Medicine and Geriatrics.  She serves on the Medicare Payment Advisory Commission and is on the Board of Directors for Welltower and previously served on the Board of Humana.  She is the President of the Society of General Internal Medicine and Honorary Vice President, United States, for the American Public Health Association.  She earned her MD and MPH from Tulane University, and a masters in clinical epidemiology from the Harvard School of Public Health.

Judith Faulkner, MS

Judy Faulkner is CEO and founder of Epic, which she began in 1979 in the basement of an apartment house with $70,000 in start-up money and 2 half-time assistants. Epic has grown by its bootstraps, without venture capital or going public.

Judy received honorary doctorates from the University of Wisconsin and from Mount Sinai in New York, an MS in Computer Science from the UW, and a BS in Mathematics from Dickinson College. After teaching computer science for several years she then worked as a software developer, creating one of the first databases organized around the patient.

Judy currently serves on the UW Computer Science Board of Visitors, is a member of the National Academy of Medicine’s Leadership Roundtable and of the Aspen Health Strategy Group. She has pledged that 99% of her assets will go to philanthropy.

David Feinberg, MD, MBA

As Cerner’s president and CEO, David Feinberg, M.D., focuses on delivering tools and technology that help caregivers optimize the health of their patients and communities.

As a pediatric psychiatrist, David built his early career around helping children and families. He served as president and CEO of both UCLA Health and Geisinger Health prior to assuming leadership of Google Health in early 2019.

His work at UCLA provided David a clear view of how patient satisfaction translates to clinical success. His focus on the patient experience increased UCLA’s patient satisfaction scores from the 28th to the 99th percentile.

At Geisinger, David led a complex turnaround that made Geisinger one of the nation’s most innovative healthcare providers, including a first-of-its kind clinical program that made DNA sequencing a routine part of patient care. David also guided Geisinger’s transition to value-based care using Cerner’s population health platform, HealtheIntent, integrated with a non-Cerner EMR.

At Google, David leveraged Google’s technology, talent and search capabilities to tackle healthcare’s most important challenges. Under David’s leadership, Google was at the forefront of using Artificial Intelligence and mobile platforms to improve healthcare and – in partnership with Ascension Health – produced Care Studio, a tool that organizes patient records for healthcare clinicians at the point of care.

David began his career at UCLA, researching and publishing in the areas of addiction and attention deficit hyperactivity disorder. He took on additional leadership responsibilities, including becoming the Medical Director of the Resnick Neuropsychiatric Hospital. By implementing rigorous service metrics and patient satisfaction measures and completing a financial turnaround, UCLA’s neuropsychiatric hospital is now considered the premier psychiatric hospital in the western United States.

David earned his M.D. from Chicago Medical School in 1989, finishing at the top of his class and is a member of the Alpha Omega Alpha Medical Honor Society. He also holds an economics degree from the University of California-Berkeley and an MBA from Pepperdine University.

Julie L. Gerberding, MD, MPH

Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the Merck for Mothers program and the Merck Foundation. As Chief Patient Officer, Dr. Gerberding leads efforts to engage with patients and patient organizations to bring their perspectives into Merck and MSD to help inform company decisions and represents Merck globally on patient-related matters. In addition, she is building new initiatives designed to accelerate Merck’s ability to contribute to improved population health, a measure increasingly valued by consumers, health organizations, and communities.

As a world-renowned infectious disease and public health expert, Dr. Gerberding is a leader well-versed in and passionate about acting with purpose and urgency to meet patient needs. She joined Merck in January 2010 as president of Merck Vaccines and, during her leadership of that business, helped make the company’s vaccines increasingly more available and affordable to people in emerging markets and some of the most resource-limited countries in the world. Dr. Gerberding also helped lead the successful launch in India of the MSD Wellcome Trust Hilleman Laboratories, a not-for-profit joint venture for vaccine development. In 1998, she left her tenured academic faculty appointment at the University of California, San Francisco, to lead the U.S. Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion and then served as the CDC Director from 2002 to 2009.

As director, Dr. Gerberding led the CDC through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS, and natural disasters. She also advised governments around the world on urgent issues such as pandemic preparedness, AIDS, antimicrobial resistance, tobacco, and cancer. At the University of California, San Francisco (UCSF), Dr. Gerberding directed the Prevention Epicenter, a multidisciplinary research, training, and clinical service program that focused on the prevention of infections in patients and their healthcare providers.

Dr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University (CWRU). She completed her internship and residency in Internal Medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco (UCSF), where she is currently an Adjunct Associate Clinical Professor of Medicine in Infectious Diseases. Dr. Gerberding received a Masters of Public Health at the University of California, Berkeley. She is a member of the Institute of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians, and is board certified in Internal Medicine and Infectious Diseases.

Dr. Gerberding currently serves on the Boards of Cerner Corporation, CWRU, MSD Wellcome Trust Hilleman Laboratories, and the BIO Executive Committee. Dr. Gerberding has received more than 50 awards and honors, including the United States Department of Health and Human Services (DHHS) Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks. In 2018, she was selected as the Healthcare Businesswomen Association’s Woman of the Year and received the Lifetime Achievement Award from eyeforpharma. Previously, Dr. Gerberding was named to Forbes Magazine’s 100 Most Powerful Women in the World in 2005 through 2008 and to TIME Magazine’s 100 Most Influential People in the World in 2004.

Sandra R. Hernández, MD

Sandra R. Hernández, MD is president and CEO of the California Health Care Foundation. Prior to joining CHCF, Sandra was CEO of The San Francisco Foundation, which she led for 16 years. She previously served as director of public health for the City and County of San Francisco. She also co-chaired San Francisco’s Universal Healthcare Council, which designed Healthy San Francisco, an innovative health access program for the uninsured.

Sandra is an assistant clinical professor at the University of California, San Francisco, School of Medicine. She practiced at San Francisco General Hospital in the AIDS clinic from 1984 to 2016. She was appointed by Governor Jerry Brown to the Covered California board of directors in February 2018. She currently serves on the Betty Irene Moore School of Nursing Advisory Council at UC Davis and the UC Regents Committee on Health Services. Sandra served on the External Advisory Committee at the Stanford Center for Population Health Sciences in 2016. Sandra is a graduate of Yale University, the Tufts School of Medicine, and the certificate program for senior executives in state and local government at Harvard University’s John F. Kennedy School of Government.

Diane P. Holder, MS

Diane P. Holder is executive vice president and president of the UPMC Insurance Services Division, and president and CEO of UPMC Health Plan. UPMC is one of the nation’s leading integrated delivery systems and through its health plans and affiliates, provides health coverage and benefit management for 3.4 million men, women and children in Pennsylvania. The Insurance Services Division includes the UPMC Health Plan, UPMC for You, Community Care Behavioral Health Organization and Work Partners. These health benefits companies manage benefits for Commercial, Medicaid, Medicare, Behavioral Health, EAP, Health Promotions and Worker’s Compensation programs.

Ms. Holder has held a number of leadership positions in health care including the CEO of UPMC’s Western Psychiatric Institute and Clinic and the founding CEO of Community Care Behavioral Health Organization. Ms Holder is a faculty member of the University of Pittsburgh Department of Psychiatry and a faculty member of Pitt’s Graduate School of Public Health. She received her undergraduate degree from the University of Michigan and her master’s degree from Columbia University.
Michelle Hood, MPA

Michelle Hood is the executive vice president and chief operating officer of the American Hospital Association. Previously she served as president and CEO of Northern Light Health, a Brewer, Maine-based, $1.8 B integrated health system providing services across the state of Maine. During 14 years in this role, she oversaw significant organic growth of the system as well as addition of three hospitals, four skilled-nursing facilities, a home-care agency, residential hospice services and numerous ground/air ambulance units. She also focused on healthcare policy and design models at the state and national levels, keenly aware of Northern Light’s need to succeed in a rapidly changing healthcare environment.

Prior to Maine, Hood served as the president and CEO of the Sisters of Charity of Leavenworth Health Systems, Montana Region, as well as president and CEO of the Region’s flagship hospital, St. Vincent Healthcare. Before coming to the AHA, she served on the Association’s Board of Trustees and Executive Committee and on the University of Maine System Board of Trustees. 

Frederick Isasi, JD, MPH

Frederick Isasi was selected to be Families USA’s second-ever Executive Director in January 2017 because of his life-long commitment to achieving high-quality, affordable health care for all. He also brings to his position deep expertise in Medicaid, Medicare, and private health insurance, health equity, and payment and delivery reform. In addition, he has a proven track record of working effectively in a bipartisan manner with policymakers at the national and state levels. Mr. Isasi has testified frequently in front of Congress on health policy issues in both the U.S. Senate and House. Mr. Isasi’s skills and experiences made him the ideal choice to lead Families USA into the future as the premier voice for all families and health care consumers in America.

As Executive Director, Mr. Isasi leads the expert staff at Families USA as the organization focuses on four key challenges: Creating a value-based health system that ensures higher-quality, lower-cost health care; Helping people overcome barriers to health and health care based on race, ethnicity, income, gender, demography, or sexual orientation; Making comprehensive and affordable health insurance available to all; and Empowering health care consumers to ensure that their voices are heard in their state and local communities as well as in Washington, D.C.

Mr. Isasi’s passion for health care reform began when he was growing up in North Carolina as the son of Cuban immigrants. There, he saw firsthand many of the barriers to health care experienced by the poor, people of color, people with language barriers, and rural communities. In his 20s, Mr. Isasi was a leader of various gay rights and AIDS/HIV student organizations. He also founded a volunteer organization that provided support to the children of parents dying from AIDS and a summer camp for children with HIV/AIDS in North Carolina and Wisconsin.

Before joining Families USA, Mr. Isasi served as the Health Division Director at the bipartisan National Governors Association’s (NGA) Center for Best Practices. In this position, he worked directly with governors of both parties and as NGA’s national voice on issues such as health care delivery and payment reform, improving Medicaid, and health exchange planning and oversight. He also directed technical assistance for states as they navigated changes to their health care systems.

Prior to NGA, Mr. Isasi served as Vice President for Health Policy at the Advisory Board Company—a leading national and international private-sector group that advises 3,100 hospitals, health systems, provider groups, and payers—where he founded its Health Policy Department. Under Mr. Isasi’s leadership, the Advisory Board sought new opportunities to leverage the power of health system data and develop evidence-based policy solutions to modern health care challenges. He also broadened the Advisory Board’s work with policymakers in Congress, the Administration, and states to improve health care transformation efforts across the nation.

As Congress was developing the groundbreaking Affordable Care Act legislation, Mr. Isasi served as Senior Legislative Counsel for Health Care on both the U.S. Senate Finance Committee and Senate Committee on Health, Education, Labor, and Pensions (HELP) for former Senator Jeff Bingaman (D-NM), the only Democrat serving on both committees during the creation of the Affordable Care Act. Mr. Isasi was the Senator’s principal negotiator during closed-door, bipartisan negotiations. He also served as the Senator’s advisor and chief negotiator on the Children’s Health Insurance Program (CHIP) Reauthorization Act of 2009 and various Medicare bills, and directed the Senator’s leadership efforts to address the health care challenges brought on by low-income, cultural, and racial disparities.

Earlier in his career, Mr. Isasi served as a health care attorney with Powell Goldstein, where he worked closely with states on Medicaid reforms and represented public hospitals; prior to that, he served as Senior Policy Advisor to the District of Columbia Primary Care Association.

Mr. Isasi is a well-known and respected national speaker on Medicaid, state innovation, health system transformation, behavioral health, and the social determinants of health as well as health care quality, payment, and equity issues. He has served on myriad expert panels and boards, including the National Academy of Medicine, Brookings Institution, National Committee for Quality Assurance, Duke University Margolis Center for Health Policy, Catalyst for Payment Reform, the Health Care Payment Learning & Action Network (LAN) and Bipartisan Policy Center. He holds a JD from Duke University, where he was a Pamela B. Gann Scholar and a staff editor of the Duke Journal of Gender Law and Policy, an M.P.H. from the University of North Carolina, where he was inducted into both the Delta Omega and the Frank Porter Graham honor societies, and a B.S. in Cellular Biology and a second major in Spanish from the University of Wisconsin, where he was a Powers-Knapp Scholar.

Richard E. Kuntz, MD, MS

Dr. Rick Kuntz is Senior Vice President, Chief Medical and Scientific Officer of Medtronic and serves as a member of the Company’s Executive Committee. In this role, Kuntz oversees the company’s medical affairs, health policy and reimbursement, clinical research activities, and corporate technology.

Kuntz joined Medtronic in October 2005, as Senior Vice President and President of Medtronic Neuromodulation, which encompasses the company’s products and therapies used in the treatment of chronic pain, movement disorders, spasticity, overactive bladder and urinary retention, benign prostatic hyperplasia, and gastroparesis. In this role he was responsible for the research, development, operations and product sales and marketing for each of these therapeutic areas worldwide.

Kuntz brings to Medtronic a broad background and expertise in many different areas of healthcare. Prior to Medtronic he was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute (HCRI), a university-based contract research organization which coordinates National Institutes of Health (NIH) and industry clinical trials with the United States Food and Drug Administration (FDA). Kuntz has directed over 100 multicenter clinical trials and has authored more than 250 original publications. His major interests are traditional and alternative clinical trial design and biostatistics.

Kuntz also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women’s Hospital in Boston, MA. Kuntz has served as a member of the Board of Governors of PCORI (Patient Centered Outcomes Research Institute) since it was established in 2010 as part of the Affordable Care Act.

Kuntz graduated from Miami University, and received his medical degree from Case Western Reserve University School of Medicine. He completed his residency and chief residency in internal medicine at the University of Texas Southwestern Medical School, and then completed fellowships in cardiovascular diseases and interventional cardiology at the Beth Israel Hospital and Harvard Medical School, Boston. Kuntz received his Master’s of science in biostatistics from the Harvard School of Public Health.

Adam Lenkowsky

Adam Lenkowsky is General Manager, Head of US Commercial at Bristol-Myers Squibb.

Peter Long, PhD

Peter Long is senior vice president of Healthcare and community Health Transformation at Blue Shield of California, a 4-million-member nonprofit health plan that serves the state’s commercial, individual, and government markets. Long leads collaborations with health care providers, community leaders, and other stakeholders to design innovative clinical and community programs, and health care delivery and payment systems that provide all Californians access to value-based, high quality, and affordable care.

Previously, Long was President and CEO of Blue Shield of California Foundation for nearly nine years, focusing on building lasting and equitable solutions to make California the healthiest state and end domestic violence. He helped launch the California Accountable Communities for Health Initiative in 15 communities across the state in partnership with California Department of Public Health and other philanthropies. Under his leadership in partnership with the center for Care Innovations, the Foundation supported successful implementation of the Affordable Care Act among the safety-net providers for Californians who has been excluded from health care.

Long served in leadership roles at the Henry J. Kaiser Family Foundation and The California Endowment. He has extensive experience working on health policy issues at the state and national levels. He has written numerous papers and chapters on a variety of health policy topics. His research and 20+ publications have been groundbreaking in health care reform and community development.

Long also served as the director of development and programs and then executive director of the Indian Health Center of Santa Clara Valley in San Jose. Previously, he served as a legislative analyst for the National Progressive Primary Health Care Network in Cape Town, South Africa, during the country’s transition to democracy.

Long earned a bachelor’s degree from Harvard University, a master’s degree from Johns Hopkins Bloomberg School of Public Health, and a doctorate from UCLA Fielding School of Public Health.

Long serves as an adjunct professor at the UCLA Fielding School of Public Health. He also serves as a co-chair of the Foresight Project, which is envisioning, testing, and creating a transformed future U.S> health system. He has been a board member at Grantmakers for Effective Organizations, Grantmakers in Health, and the Institute for Clinical and Economic Review, and serves on a number of other health advisory councils.

James L. Madara, MD

James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association, the nation’s largest physician organization. He holds the academic title of adjunct professor of pathology at Northwestern University.

Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization’s visionary longterm strategic plan. As an extension of this vision, he now also serves as chairman of Health2047 Inc., an independent, design-driven innovation firm based in San Francisco and whose mission is to help advance the AMA’s goal of improving the health of the nation.

Prior to arriving at the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following five years as chair of pathology at Emory, Dr. Madara served as dean of the medical school and CEO of the hospitals at the University of Chicago, bringing together the university’s biomedical research, teaching and clinical activities. While there he oversaw the renewal of the institution’s biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations.

Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Secretary of Health and Human Services, Mike Leavitt.

Having published more than 200 original papers and chapters, Dr. Madara has received both national and international awards, and served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology.

In addition to Modern Healthcare consistently naming him as one of the nation’s 50 most influential physician executives, as well as one of the nation’s 100 most influential people in health care, he is a past recipient of a prestigious MERIT Award from the National Institutes of Health. He received the 2011 Davenport Award for lifetime achievement
in gastrointestinal disease from the American Physiological Society and the 2011 Mentoring Award for lifetime achievement from the American Gastroenterological Society.

Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also cochairs the Value Incentives and Systems Innovation Collaborative of the National Academy of Medicine (NAM), and is a member of NAM’s Leadership Consortium for Value & Science-Driven Health Care.

Suzanne Miyamoto, PHD, RN

Dr. Miyamoto is Chief Executive Officer of the American Academy of Nursing. Dr. Miyamoto has held previous academic positions at the University of Michigan, School of Nursing, University of New Mexico, School of Nursing, and Johns Hopkins University, School of Nursing. She is a Senior Associate Editor for the journal Policy, Politics & Nursing Practice. Previously, she held policy positions at the state and federal level with the National Institutes of Health, the State Commission on Patient Safety for the Michigan Health and Safety Coalition, and former United States Congressman Joseph Knollenberg. Dr. Miyamoto’s areas of research, publications, and presentations (national and international) focus on health policy, coalition building, and political advocacy. Dr. Miyamoto received her Bachelor of Science in Nursing, Bachelor of Arts in Psychology, Master of Science in Nursing, and Doctorate of Philosophy in Nursing from the University of Michigan, Ann Arbor. She is a member of Sigma Theta Tau International, Women in Government Relations, Academy Health, the American Organization of Nurse Executives, and the American Nurses Association. Dr. Miyamoto is a Fellow of the American Academy of Nursing and an Honorary Friend of the National Institute of Nursing Research.

Valerie Montgomery Rice, MD, FACOG

Valerie Montgomery Rice, MD, FACOG, provides a valuable combination of experience at the highest levels of patient care and medical research, as well as organizational management and public health policy. Marrying her transformational leadership acumen and strategic thinking to tackle challenging management issues, she has a track record of redesigning complex organizations’ infrastructures to reflect the needs of evolving strategic environments and position the organization for success through sustainability tactics.  

The sixth president of Morehouse School of Medicine (MSM) and the first woman to lead the free-standing medical institution., Montgomery Rice serves as both the president and dean. A renowned infertility specialist and researcher, she most recently served as dean and executive vice president of MSM, where she has served since 2011.  

Prior to joining MSM, Montgomery Rice held faculty positions and leadership roles at various health centers, including academic health centers.  Most notably, she was the founding director of the Center for Women’s Health Research at Meharry Medical College, one of the nation’s first research centers devoted to studying diseases that disproportionately impact women of color.  

Dedicated to the creation and advancement of health equity, Montgomery Rice lends her vast experience and talents to programs that enhance pipeline opportunities for academically diverse learners, diversifies the physician and scientific workforce, and fosters equity in health care access and health outcomes. To this end, she holds memberships in various organizations and participates on a number of boards, such as the following: member, National Academy of Medicine, and board of directors for National Center for Advancing Translational Sciences, The Metro Atlanta Chamber, Kaiser Permanente School of Medicine, The Nemours Foundation, UnitedHealth Group, Westside Future Fund, Josiah Macy Jr. Foundation, the Association of American Medical Colleges Council of Deans, and Horatio Alger Association.

Montgomery Rice has received numerous accolades and honors. She was named to the Horatio Alger Association of Distinguished Americans and received the 2017 Horatio Alger Award. For three consecutive years (2016-2018) Georgia Trend Magazine selected Montgomery Rice as one of the 100 Most Influential Georgians. Other honors include the following: The Turknett Leadership Character Award (2018), Visions of Excellence Award, Atlanta Business League (2018), Links Incorporated Co-Founders Award (2018), Trumpet Vanguard Award (2015), The Dorothy I. Height Crystal Stair Award (2014), National Coalition of 100 Black Women – Women of Impact (2014), YWCA – Women of Achievement of Atlanta-(2014) and Nashville(2007), American Medical Women’s Association Elizabeth Blackwell Medal (2011) and Working Mother Media Multicultural Women’s Legacy Award (2011).  

A Georgia native, Montgomery Rice holds a bachelor’s degree in chemistry from the Georgia Institute of Technology, a medical degree from Harvard Medical School and an honorary degree from the University of Massachusetts Medical School and Doctor of Humane Letters honorary degree from Rush University.  All reflect her lifetime commitment to education, service, and the advancement of health equity.  She completed her residency in obstetrics and gynecology at Emory University School of Medicine and her fellowship in reproductive endocrinology and infertility at Hutzel Hospital.   

Mary D. Naylor, PhD, FAAN, RN

Mary D. Naylor, PhD, FAAN, RN, is the Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. For more than two decades, Dr. Naylor has led a multidisciplinary team of clinical scholars and health services researchers in generating and disseminating research findings designed to enhance the care and outcomes of chronically ill older adults and their family caregivers. She is the architect of the Transitional Care Model, a care management approach proven in multiple NIH clinical trials and foundation sponsored translational efforts to improve older adults’ experience with care and health outcomes, while decreasing use of costly health services. Dr. Naylor is the 2016 recipient of AcademyHealth’s Distinguished Investigator Award, a recognition of significant and lasting contributions to the field of health services research. She was elected to the National Academy of Medicine (NAM) in 2005. For eight years, she served as the national program director for the Robert Wood Johnson Foundation sponsored Interdisciplinary Nursing Quality Research Initiative. She recently completed six-year terms as a commissioner on the Medicare Payment Advisory Commission (MedPAC), board member of the National Quality Forum and member of the Agency for Healthcare Research and Quality’s National Advisory Council. Currently, Dr. Naylor is a member of the NAMs Leadership Consortium on Value & Science-Driven Health Care and co-chairs NAMs Care Culture and Decision-Making Innovation Collaborative. Dr. Naylor also is a member of the RAND Health Board of Advisors, the Institute for Health Improvement’s Scientific Advisory Group, and the Board of Trustees of the Dorothy Rider Pool Health Care Trust.

Bill Novelli, MA

Bill Novelli is a professor in the McDonough School of Business at Georgetown University. He teaches in the MBA program and has created and leads the Global Social Enterprise Initiative at the School. He also is Co-Chair of the Coalition to Transform Advanced Care (C-TAC), a national organization dedicated to reforming advanced illness care by empowering consumers, changing the health care delivery system, improving public policies and enhancing provider capacity. From 2001 to 2009, he was CEO of AARP, a membership organization of over 40 million people 50 and older. During his tenure, AARP achieved important policy successes at national and state levels in health, financial security, good government and other areas. It also doubled its budget, added five million new members and expanded internationally.

Prior to AARP, Mr. Novelli was President of the Campaign for Tobacco-Free Kids, whose mandate is to change public policies and the social environment, limit tobacco companies’ marketing and sales practices to children and serve as a counterforce to the tobacco industry and its special interests. He now serves as chairman of the board.

Previously, he was Executive Vice President of CARE, the world’s largest private relief and development organization. He was responsible for all operations in the U.S. and abroad. CARE helps impoverished people in Africa, Asia and Latin America through programs in health, agriculture, environmental protection and small business support. CARE also provides emergency relief to people in need.

Earlier, Mr. Novelli co-founded and was President of Porter Novelli, now one of the world’s largest public relations agencies and part of the Omnicom Group, an international marketing communications corporation. He directed numerous corporate accounts as well as the management and development of the firm. Porter Novelli was founded to apply marketing to social and health issues, and grew into an international marketing/public relations agency with corporate, not-for-profit and government clients. He retired from the firm in 1990 to pursue a second career in public service. He was named one of the 100 most influential public relations professionals of the 20th century by the industry’s leading publication.

Mr. Novelli is a recognized leader in social marketing and social change, and has managed programs in cancer control, diet and nutrition, cardiovascular health, reproductive health, infant survival, pay increases for educators, charitable giving and other programs in the U.S. and the developing world.

He began his career at Unilever, a worldwide-packaged goods marketing company, moved to a major ad agency, and then served as Director of Advertising and Creative Services for the Peace Corps. In this role, Mr. Novelli helped direct recruitment efforts for the Peace Corps, VISTA, and social involvement programs for older Americans.

He holds a B.A. from the University of Pennsylvania and an M.A. from Penn’s Annenberg School for Communication, and pursued doctoral studies at New York University. He taught marketing management for 10 years in the University of Maryland’s M.B.A. program and also taught health communications there. He has lectured at many other institutions. He has written numerous articles and chapters on marketing management, marketing communications, and social marketing in journals, periodicals and textbooks.

His book, 50+: Give Meaning and Purpose to the Best Time of Your Life, was updated in 2008. His newest book, Managing the Older Worker: How to Prepare for the New Organizational Order (with Peter Cappelli) was published in 2010.

Harold Paz, MD, MS

Harold “Hal” Paz, M.D., M.S., was named executive vice president for health sciences at Stony Brook University effective October 4, 2021.

Previously executive vice president and chancellor for health affairs at The Ohio State University and chief executive officer of the Ohio State Wexner Medical Center, Paz works in partnership with academic, hospital and clinical leadership and with community partners to ensure the continued development of a premier academic medical center and health system.

At Ohio State, where he was also a professor of medicine and public health sciences, Paz  was responsible for seven health science colleges including more than 20 research institutes and an NCI-designated comprehensive cancer center. He also served as CEO of the Ohio State Wexner Medical Center, a health system that includes seven hospitals, 16 network hospitals, more than 100 outpatient sites, a multispecialty practice, an accountable care organization and a health plan.

A member of the National Academy of Medicine’s Leadership Consortium and the board of directors of Research! America, Paz has nearly 25 years of leadership in health care and academic medicine. Prior to joining Ohio State, he was the executive vice president and chief medical officer for CVS Health/Aetna where he provided clinical leadership for the company’s domestic and global businesses. He was also a professor adjunct of internal medicine at Yale University School of Medicine. Prior to his experience in the private sector, Paz served as senior vice president for health affairs, dean of the college of medicine at Pennsylvania State University, and CEO of the Penn State Hershey Medical Center and Health System.

Dr. Paz received his bachelor’s degree from the University of Rochester, a master of science in life science engineering from Tufts University and his medical degree from the University of Rochester School of Medicine and Dentistry. He completed his residency at Northwestern University, where he served as chief medical resident. Dr. Paz was a Eudowood Fellow in pulmonary and critical care medicine at Johns Hopkins Medical School. In addition, he was a postdoctoral fellow in environmental health science at Johns Hopkins School of Hygiene and Public Health.

Jonathan B. Perlin, MD, PhD

Jonathan B. Perlin, MD, PhD, is President, Clinical Services and Chief Medical Officer of Nashville, Tennessee-based HCA Healthcare. He provides leadership for clinical services and improving performance at HCA’s 178 hospitals and approximately 2,000 outpatient surgical, urgent care and other practice units. Current activities include advancing electronic health records for learning healthcare and continuous improvement, driving value through data science and elevating measured clinical performance and patient safety to benchmark levels. His team conducted some of the world’s largest comparative effectiveness trials, including the landmark REDUCE MRSA study, demonstrating a 44 percent improvement on known best practices for reducing bloodstream infections in ICU patients and the ABATE study which reduced line infections one-third in non-ICU settings.

Before joining HCA in 2006, “the Honorable Jonathan B. Perlin” was Under Secretary for Health in the U.S. Department of Veterans Affairs. Nominated by the President and confirmed by the Senate, as the senior-most physician in the Federal Government and Chief Executive Officer of the Veterans Health Administration (VHA), Dr. Perlin led the nation’s largest integrated health system.
At VHA, Dr. Perlin directed care to 5.5 million patients annually by more than 250,000 healthcare professionals at 1,400 sites, including hospitals, clinics, nursing homes, counseling centers and other facilities, with an operating and capital budget of $37.4 billion. A champion for early implementation of electronic health records, Dr. Perlin led VHA quality performance to international recognition as reported in academic literature and lay press and as evaluated by RAND, the Institute of Medicine, and others.

Dr. Perlin is a member of the Medicare Payment Advisory Commission (MedPAC) and the Congressional Budget Office Panel of Health Advisors. He also serves as chair of the Secretary of Veterans Affairs’ Special Medical Advisory Group. Dr. Perlin was the 2015 chairman of the American Hospital Association. In 2014, Dr. Perlin took a “sabbatical” from HCA to serve as Senior Advisor to the Secretary of Veterans Affairs to help improve operations, accelerate access and rebuild trust with America’s Veterans. Dr. Perlin has served previously on numerous Boards and Commissions including the Joint Commission and the National Patient Safety Foundation and currently serves on the Board of Meharry Medical College and the National Quality Forum. He was the inaugural chair of the U.S. Department of Health and Human Services Health IT Standards Committee.

A member of the National Academy of Medicine (NAM), co-chair of NAM’s Action Collaborative on Countering the U.S. Opioid Epidemic, Perlin is recognized perennially as one of the most influential physician executives and health leaders in the United States by Modern Healthcare. He has received numerous awards including Distinguished Alumnus in Medicine and Health Administration from his alma mater, Chairman’s Medal from the National Patient Safety Foundation, the Founders Medal from the Association of Military Surgeons of the United States, and is one of the few honorary members of the Special Forces Association and Green Berets.

Broadly published in healthcare quality and transformation, Dr. Perlin is a Master of the American College of Physicians and Fellow of the American College of Medical Informatics. He has a Master of Science in Health Administration and received his Ph.D. in pharmacology (molecular neurobiology) with his M.D. as part of the Physician Scientist Training Program at the Medical College of Virginia of Virginia Commonwealth University (VCU).

Dr. Perlin has faculty appointments at Vanderbilt University as Clinical Professor of Medicine and Biomedical Informatics and at VCU as Adjunct Professor of Health Administration. He resides in Nashville, Tennessee, with his wife, Donna, an Emergency Pediatrics Physician.

Richard Platt, MD, MS

Richard Platt, MD, MSc is Professor and Chair of the Harvard Medical School Department of Population Medicine at the Harvard Pilgrim Health Care Institute. He is principal investigator of the FDA’s Sentinel System that studies of the safety and effectiveness of marketed medical products. Dr. Platt is also co-principal investigator of the coordinating center of PCORI’s Patient Centered Outcomes Research Institute, leads the NIH Health Care Systems Research Collaboratory’s Distributed Research Network, and is co-principal of a CDC Prevention Epicenter. He is a member of the Association of American Medical Colleges’ Advisory Panel on Research. He is a former chair of the FDA’s Drug Safety and Risk Management Advisory Committee, and co-chair of the Board of Scientific Counselors of the Centers for Disease Control and Prevention’s (CDC) Center for Infectious Diseases.

Dwayne Proctor, PhD

Dwayne Proctor is the President and CEO of the Missouri Foundation for Health.

During his nearly 20 years in philanthropy, Proctor has always worked to ensure various communities were healthy and thriving. He arrived at RWJF in 2002 as a senior communications and program officer, providing strategic guidance and resources for several child health and risk-prevention initiatives such as Nurse-Family Partnership, Free to Grow, Leadership to Keep Children Alcohol-Free, Partnership for a Drug-Free America, and the National Campaign to Prevent Teenage Pregnancy.

In 2005, Proctor was tapped to lead RWJF’s national strategies to reverse the rise in childhood obesity rates. In this role, he worked with his colleagues to promote effective changes to public policies and industry practices; test and demonstrate innovative community and school-based environmental changes; and use both “grassroots” and “treetops” advocacy approaches to educate leaders on their roles in preventing childhood obesity. His work at RWJF has been varied and extensive, preparing him for his new role as a Missouri changemaker.

Before RWJF, Proctor was an assistant professor at the University of Connecticut School of Medicine where he taught courses on health communication and marketing to multicultural populations. During his Fulbright Fellowship in Senegal, West Africa, his research team investigated how HIV/AIDS prevention messages raised awareness of AIDS as a national health problem. Proctor received his doctoral, master’s and bachelor’s degrees in marketing and communication science from the University of Connecticut. He is the former chairman of the board of directors for the Association of Black Foundation Executives and currently is the chairman of the board of trustees for the National Association for the Advancement of Colored People Foundation.

John W. Rowe, MD

John Rowe, MD is a Professor in the Department of Health Policy and Management at the Columbia University Mailman School of Public Health. Previously, from 2000 until his retirement in late 2006, Dr. Rowe served as Chairman and CEO of Aetna, Inc., one of the nation’s leading health care and related benefits organizations. Before his tenure at Aetna, from 1988 to 2000, Dr. Rowe served as President and Chief Executive Officer of Mount Sinai NYU Health, one of the nation’s largest academic health care organizations. From 1988 to 1998, prior to the Mount Sinai-NYU Health merger, Dr. Rowe was President of the Mount Sinai Hospital and the Mount Sinai School of Medicine in New York City.

Before joining Mount Sinai, Dr. Rowe was a Professor of Medicine and the founding Director of the Division on Aging at the Harvard Medical School, as well as Chief of Gerontology at Boston’s Beth Israel Hospital. He has authored over 200 scientific publications, mostly on the physiology of the aging process, including a leading textbook of geriatric medicine, in addition to more recent publications on health care policy. Dr. Rowe has received many honors and awards for his research and health policy efforts regarding care of the elderly. He was Director of the MacArthur Foundation Research Network on Successful Aging and is co-author, with Robert Kahn, Ph.D., of Successful Aging (Pantheon, 1998). Currently, Dr. Rowe leads the MacArthur Foundation’s Network on An Aging Society.

He has served as president of the Gerontological Society of America and recently chaired the Committee of the Institute of Medicine of the National Academy of Sciences on The Future Health Care Workforce Needs of An Aging Population. Dr. Rowe was elected a Fellow of the American Academy of Arts and Sciences and a member of the Institute of Medicine of the National Academy of Sciences where he is involved in the Evidence Based Roundtable. Dr. Rowe serves on the Board of Trustees of the Rockefeller Foundation and is Chairman of the Board of Trustees at the Marine Biological Laboratory in Woods Hole, Massachusetts. Dr Rowe is a former member of the Medicare Payment Advisory Commission (MedPAC).

Kyu Rhee, MD, MPP

Kyu Rhee, M.D., MPP, is a Senior Vice President at CVS Health and Chief Health & Medical Officer of Aetna.

Dr. Rhee joined CVS Health from IBM, where he served for a decade as Vice President and Chief Health Officer, and was the lead physician, public health and clinical executive leader for IBM’s global workforce of over 350,000 in 170 countries. He had global responsibilities for IBM’s efforts to transform health through the use of data, analytics, artificial intelligence, and services for hospitals, health systems, providers, health plans, employers, governments, and life science companies. Most recently, he and his team led many of IBM’s global COVID-19 and Culture of Health initiatives.

Before joining IBM, Dr. Rhee served in the federal government as Chief Public Health Officer at the Health Resources and Services Administration (HRSA) and Director of Innovation at the National Institutes of Health (NIH). While at HRSA and NIH, he led numerous national initiatives related to prevention, health care quality, research, health equity and public health. 

Dr. Rhee earned his dual medical residency training in internal medicine and pediatrics from Cedars-Sinai Medical Center in Los Angeles, his medical degree from the Keck School of Medicine at the University of Southern California, a master’s degree in Healthcare Policy from Harvard University’s Kennedy School of Government, and a BS in Molecular Biophysics and Biochemistry from Yale University. Earlier in his career, Dr. Rhee worked as a National Health Services Corps primary care physician and Chief Medical Officer in diverse community health settings in Washington, D.C., and Baltimore. He also taught and mentored clinical and public health students at George Washington University’s Schools of Public Health and Medicine.

Lewis G. Sandy, MD

Lewis G. Sandy, MD, is Executive Vice President, Clinical Advancement, UnitedHealth Group (a Fortune 25 diversified health and well-being company dedicated to helping people live healthier lives). At UnitedHealth Group he focuses on clinical innovation, payment/delivery reforms to modernize our health care system, and physician collaboration. He also is a Principal in the UnitedHealth Center for Health Reform and Modernization, with a focus on payment/delivery innovation and policy. From 2003 to 2007, he was EVP and Chief Medical Officer of UnitedHealthcare, UnitedHealth Group’s largest business focusing on the employer/individual health benefits market. From 1997 to 2003, he was EVP of The Robert Wood Johnson Foundation. At RWJF, he was responsible for the Foundation’s program development and management, strategic planning and administrative operations. Prior to this, Dr. Sandy was a program VP of the Foundation, focusing on the Foundation’s workforce, health policy, and chronic care initiatives. An internist and former health center medical director at the Harvard Community Health Plan in Boston, Massachusetts, Dr. Sandy received his B.S. and M.D. degrees from the University of Michigan and an M.B.A. degree from Stanford University. A former RWJF Clinical Scholar and Clinical Fellow in Medicine at the University of California, San Francisco, Dr. Sandy served his internship and residency at the Beth Israel Hospital in Boston. He is a Senior Fellow of the University of Minnesota School of Public Health, Department of Health Policy and Management.

Leonard D. Schaeffer

Leonard D. Schaeffer is the founding Chairman & CEO of WellPoint (now Anthem), the nation’s largest health benefits company by membership. WellPoint serves over 40 million medical members and has annualized revenues of $90 billion. He is currently the Judge Robert Maclay Widney Chair and Professor at the University of Southern California and is a Senior Advisor to TPG Capital and Starr Investment Holdings, private equity firms. Schaeffer was the founding Chairman & CEO of WellPoint from 1992 through 2004 and continued to serve as Chairman through 2005. Under his leadership, WellPoint was selected by FORTUNE magazine as America’s “Most Admired Health Care Company” for six consecutive years; named by BusinessWeek as one of the 50 best performing public companies for three consecutive years; and identified by Forbes magazine as America’s best large health insurance company. Mr. Schaeffer was selected by BusinessWeek magazine as one of the “Top 25 Managers of the Year” and by Worth magazine as one of the “50 Best CEOs in America.” In 1986, Mr. Schaeffer was recruited as CEO to WellPoint’s predecessor company, Blue Cross of California, when it was near bankruptcy. He managed the turnaround of Blue Cross of California and the IPO creating WellPoint in 1993. During his tenure as CEO, WellPoint made 17 acquisitions and its value grew from $11 million to over $49 billion. In 2009, Mr. Schaeffer established a new research center at USC. The Schaeffer Center for Health Policy and Economics emphasizes an interdisciplinary approach to research and analysis to promote health and value in health care delivery and to support evidence-based health policy. He has also endowed chairs in health care financing and policy at The Brookings Institution, U.C. Berkeley, the National Academy of Medicine and Harvard Medical School. Previously, Mr. Schaeffer was President and CEO of Group Health, Inc. of Minnesota, a staff model HMO. Mr. Schaeffer was also EVP and COO of the Student Loan Marketing Association, and earlier was a Vice President of Citibank and a consultant specializing in design and installation of large scale financial and management information systems. In the federal government, he served as Administrator of the Health Care Financing Administration (now CMS) and was responsible for the U.S. Medicare and Medicaid programs. He was also the Assistant Secretary for Management and Budget of the federal Department of Health and Human Services. Previously, Mr. Schaeffer was Director of the Bureau of the Budget for the State of Illinois and also served as Chairman of the Illinois Capital Development Board and as Deputy Director for Management, Illinois Department of Mental Health and Developmental Disabilities. Mr. Schaeffer is active on the boards of numerous businesses, philanthropic and professional organizations. He was awarded a Doctor of Humane Letters (Hon) from USC and received the inaugural USC Sol Price Award for his lifetime achievements as a business leader, policy expert and philanthropist. He is a member of the National Academy of Medicine. He was the Regent’s Lecturer at the University of California at Berkeley and a Gilbert Fellow at Princeton. A native of Evanston, Illinois, he is a graduate of Princeton University. Mr. Schaeffer and his wife, the former Pamela Sidford, have two children.

Bruce Siegel

With an extensive background in health care management, policy, and public health, Bruce Siegel, MD, MPH, has the blend of experience necessary to lead America’s Essential Hospitals and its members through the changing health care landscape and into a sustainable future.

Since joining America’s Essential Hospitals in 2010, Siegel has guided the association toward realizing its strategic vision of advancing the work of hospitals committed to ensuring access to care and optimal health for America’s most vulnerable people. Siegel has helped shape the association’s work in advocacy, member support, and quality. Under his leadership, America’s Essential Hospitals established a federally funded, national network of hospitals that improved patient safety and reduced care disparities by averting more than 4,000 harm events and $40 million in costs.

In 2013, Siegel led the association in a strategic rebranding to better reflect the common purpose of its more than 320 members: to serve all people and communities by providing essential services and the best care possible. The association’s new name preserves the sense of accountability central to its legacy and speaks to the essential services its members provide to communities across the country.

Siegel came to America’s Essential Hospitals with extensive experience as a hospital and health care executive. He previously served as president and CEO of two member systems: New York City Health and Hospitals Corporation (HHC) and Tampa General Healthcare. Siegel streamlined HHC’s operations, developed the system’s health maintenance organization, and redesigned the system to provide dramatically better care at lower cost for all New Yorkers. At Tampa General, Siegel guided the hospital’s conversion from public to nonprofit governance, reduced its costs by $39 million annually, increased its market share, and led the creation of the region’s first clinical research center. Siegel also served as New Jersey’s commissioner of health, where he led the state’s regionalization of key health services, several major immunization initiatives that significantly increased preschool immunization rates, and the successful negotiation of a Medicare overpayment issue that saved New Jersey hospitals $94 million.

Siegel’s hands-on member experience provided a lens through which to view his research and policy work as director of the Center for Health Care Quality and professor of health policy at The George Washington University School of Public Health and Health Services, where he served just before joining America’s Essential Hospitals. Among his many accomplishments, Siegel led groundbreaking work on quality and equity with funding from the Robert Wood Johnson Foundation and other philanthropies. He is past-chair the National Quality Forum board and the National Advisory Council for Healthcare Research and Quality. Modern Healthcare has recognized him as one of the “100 Most Influential People in Healthcare” from 2011 to 2019; one of the “50 Most Influential Physician Executives” from 2012 to 2018; and among the “Top 25 Minority Executives in Healthcare” in 2014 and 2016. He also was named one of the “50 Most Powerful People in Healthcare” by Becker’s Hospital Review in 2013 and 2014.

Siegel earned a bachelor’s degree from Princeton University, a doctor of medicine from Cornell University Medical College, and a master of public health from The Johns Hopkins University School of Hygiene and Public Health.

David Skorton, MD

David J. Skorton, MD, is president and CEO of the AAMC (Association of American Medical Colleges), a not-for-profit institution that represents the nation’s medical schools, teaching hospitals, and academic societies.

Dr. Skorton began his leadership of the AAMC in July 2019 after a distinguished career in government, higher education, and medicine.

Most recently, Dr. Skorton served as the 13th secretary of the Smithsonian Institution, where he oversaw 19 museums, 21 libraries, the National Zoo, numerous research centers, and education programs. Prior to that, he served as president of two universities: Cornell University (2006 to 2015) and the University of Iowa (2003 to 2006), where he also served on the faculty for 26 years and specialized in the treatment of adolescents and adults with congenital heart disease. A pioneer of cardiac imaging and computer processing techniques, he was co-director and co-founder of the University of Iowa Adolescent and Adult Congenital Heart Disease Clinic.

A distinguished professor at Georgetown University, Dr. Skorton is an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society, as well as a lifetime member of the Council on Foreign Relations and a fellow of the American Association for the Advancement of Science. He also served on the AAMC Board of Directors from 2010 to 2013, and was the charter president of the Association for the Accreditation of Human Research Protection Programs, Inc., the first group organized specifically to accredit human research protection programs.

Throughout his career, Dr. Skorton has focused on issues of diversity and inclusion. A nationally recognized supporter of the arts and humanities, as well as an accomplished jazz musician and composer, Dr. Skorton believes that many of society’s thorniest problems can only be solved by combining the sciences, social sciences, and the arts and humanities.

Dr. Skorton earned his BA from Northwestern University and MD from Northwestern University Feinberg School of Medicine. He completed his medical residency and fellowship in cardiology and was chief medical resident at the University of California, Los Angeles. He is married to Robin Davisson, PhD, an award-winning scientist, who is a professor of molecular physiology at the Cornell University College of Veterinary Medicine and Weill Cornell Medicine, as well as a professor of medicine at Georgetown University and an emerging visual artist.

Jennifer Taubert, MBA

Jennifer Taubert is Executive Vice President, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, the world’s premier healthcare company and fourth largest innovative pharmaceutical business. She is a member of the Corporation’s Executive Committee and leads the Pharmaceuticals Group Operating Committee.

Jennifer has been a leader in shaping Janssen’s global strategy of transformational medical innovation, successfully bringing to market critical new medicines that significantly improve the lives of patients living with cancer, immune-related diseases, heart disease and diabetes, infectious diseases including HIV, pulmonary hypertension and serious mental illness. Under her leadership Janssen has become one of the largest and fastest-growing pharmaceutical companies and a significant contributor to Johnson & Johnson growth. Jennifer is also recognized as a champion of diversity and inclusion, which she sees as critical to insight, innovation and business success.

In 2005, Jennifer joined Johnson & Johnson to lead global commercial strategy for Internal Medicine in the Pharmaceuticals Group. Later, as President, Internal Medicine, she built a powerhouse new franchise in cardiovascular and metabolic disease. Prior to joining Johnson & Johnson, Jennifer spent 18 years in positions of increasing scope and responsibility at Merck and Allergan.

Jennifer was named to Fortune magazine’s “Most Powerful Women” list in 2016 and 2017, and received the National Association for Female Executives’ 2017 “Woman of Achievement” award. In addition to her leadership at Johnson & Johnson, Jennifer represents Johnson & Johnson on the Board of Directors of the Biotechnology Innovation Organization (BIO), the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations. She is also a member of the National Academy of Medicine Leadership Consortium for Value and Science-Driven Healthcare, and at the global level, Jennifer represents Johnson & Johnson on the Executive Committee of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA).

Jennifer received a Bachelor’s degree in Pharmacology from the University of California, Santa Barbara and a Master’s of Business Administration from the Anderson Graduate School of Management, University of California, Los Angeles.

Reed V. Tuckson, MD

Reed V. Tuckson, MD, FACP, is Managing Director of Tuckson Health Connections, LLC, a vehicle to advance initiatives that support optimal health and wellbeing through the intersection of individual and community health promotion and disease prevention; applied data and analytics; enhanced quality and efficiency in care delivery; and the application of telehealth and biotech innovations.

Previously, he served as Executive Vice President and Chief of Medical Affairs for UnitedHealth Group; Senior Vice President for Professional Standards of the American Medical Association; President of the Charles R. Drew University of Medicine and Science; Commissioner of Public Health for the District of Columbia; and Senior Vice President of the March of Dimes Birth Defects Foundation.

Dr. Tuckson is honored to have been appointed to leadership roles at the National Institutes of Health; National Academy of Medicine; numerous Federal Advisory Committees; and Academic Boards.  At the National Institutes of Health, he currently serves on the Clinical Center Research Hospital Board and previous service includes his appointment to the National Advisory Council for Complementary and Integrative Health; the Advisory Committee to the Director of the National Institutes of Health and Co-Chair of the Advisory Committee to the Director’s Working Group on Diversity. Dr. Tuckson is an elected member of the National Academies of Sciences, Engineering, and Medicine and serves on the Leadership Consortium for a Value & Science-Driven Health System; the Health Sciences Policy Board; Co-Chair of the Digital Learning Collaborative; and a member of the Artificial Intelligence/Machine Learning Working Group and their Business Action Collaborative. He has served in Federal Advisory roles as a former Chairman of the Secretary of Health’s Advisory Committee on Genetics, Health and Society; as well as several U.S. Government cabinet level health advisory committees concerned with health reform, infant mortality, children’s health, violence, and radiation testing. Dr. Tuckson’s engagement on academic boards include his current service on the Board of Trustees at Howard University, where he Chairs the Health Sciences Committee; and a former member of the Board of Trustees at Rockefeller University.

Dr. Tuckson currently serves on the Board of Directors of LifePoint Health; Cell Therapeutics, Inc.; and Inform Genomics, Inc. He is Chairman of the Board for the Alliance for Health Policy; a member of the Boards of AcademyHealth and the People-Centered Research Foundation; an Advisory Board Member at Johns Hopkins Berman Institute of Bioethics and EVERMORE; and a member of the MITRE Health Advisory Committee.

Additionally, Dr. Tuckson is a former President and Board Member of the American Telemedicine Association; former Chairman of the Board of Directors for ViTel Net, LLC; and he previously served on the Board of Directors of Baxter International.

Dr. Tuckson is the author of “The Doctor in the Mirror”, an ongoing book and online senior patient activation and education project.

He is a graduate of Howard University, Georgetown University School of Medicine, and the Hospital of the University of Pennsylvania’s General Internal Medicine Residency and Fellowship Programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.

Debra B. Whitman, PhD

Debra Whitman, PhD, is AARP’s Executive Vice President, Policy and International. Dr. Whitman is an authority on aging issues with extensive experience in national policymaking, domestic and international research and the political process. Dr. Whitman oversees AARP’s Public Policy Institute, Office of Policy Integration, Office of International Affairs and Office of Academic Affairs. She works closely with the Board and National Policy Council on a broad agenda to develop AARP policy priorities and make life better for older Americans. An economist, Dr. Whitman is a strategic thinker whose career has been dedicated to solving problems affecting economic and health security, and other issues related to population aging. As Staff Director for the U.S. Senate Special Committee on Aging, she worked to increase retirement security, preserve a strong system of Social Security, lower the cost of health care, protect vulnerable seniors, safeguard consumers, make the pharmaceutical industry more transparent and improve our nation’s nursing homes. Dr. Whitman has sought bipartisan, fact-based solutions to these and other challenges facing older Americans. Before that, Dr. Whitman worked for the Congressional Research Service as a specialist in the economics of aging. In this capacity, she provided members of Congress and their staff with research and advice and authored analytical reports describing the economic impacts of current policies affecting older Americans, as well as the distributional and intergenerational effects of legislative proposals. From 2001 to 2003, she served as a Brookings LEGIS Fellow to the Senate Health, Education, Labor and Pensions Committee, working as a health policy adviser to Senator Edward M. Kennedy. Earlier in her career, she conducted research on savings and retirement for the Social Security Administration, helping to establish the Retirement Research Consortium and serving as the founding editor of the Perspectives section of the Social Security Bulletin. Dr. Whitman holds a Masters and Doctorate in Economics from Syracuse University and Bachelors in Economics, Math and Italian from Gonzaga University.

Ex Officio Members

Robert Otto Valdez, PhD, MHSA

Dr. Robert Otto Valdez, Ph.D., M.H.S.A., was appointed Director of AHRQ in February 2022. He was previously the Robert Wood Johnson Foundation (RWJF) Professor Emeritus of Family & Community Medicine and Economics at the University of New Mexico (UNM).  He received his Ph.D. from the Pardee RAND Graduate School for Public Policy Studies specializing in studies of healthcare financing and quality of medical care. At the University of Michigan School of Public Health, he was awarded a master’s degree in Health Policy & Administration. At Harvard University, Dr. Valdez studied in the Department of History and Science specializing in Latin American history and Biochemistry.

In 2008, Dr. Valdez was the Founding Executive Director of the RWJF Center for Health Policy at UNM. He previously served as founding Dean at the Drexel University School of Public Health. From 1985 through 1999, he was Professor of Health Services at the UCLA School of Public Health and directed the health services doctoral studies program, the MBA/MPH program in collaboration with the UCLA Anderson School of Business, and served as associate director of the Chicano Studies Research Center.

Dr. Valdez started his career as the lead child health researcher for the historic RAND Health Insurance Experiment. Internationally recognized as an expert in health services research, the U.S. healthcare system, and health policy analysis, he has led numerous global healthcare initiatives with the Pan American Health Organization and the University of California. His health promotion and disease prevention work with Univision Communications Corporation, “Salud es Vida: ¡Enterate!” was recognized with journalism’s prestigious Peabody Award.

From 1993 through 1997, Dr. Valdez served at the U.S. Department of Health and Human Services as Deputy Assistant Secretary for Health (Public Health Service) and simultaneously as Director of Interagency Health Policy (Centers for Medicare and Medicaid Services). 

Prior to joining DHHS in 1993, he served as a Special Senior Advisor to the White House on healthcare reform. In 1998, he served as Special Senior Advisor to the White House Initiative on Educational Excellence for Hispanic Americans. His public service includes serving as Chairman of the New Mexico Community Foundation, Chairman of the American Hospital Association Foster G McGaw Prize Committee, and Chairman of the Public Health Institute, one of the nation’s largest non-profit public health agencies serving communities across California and internationally.

Rochelle Walensky, MD, MPH

Rochelle P. Walensky, MD, MPH, is the 19th Director of the Centers for Disease Control and Prevention and the ninth Administrator of the Agency for Toxic Substances and Disease Registry. She is an influential scholar whose pioneering research has helped advance the national and global response to HIV/AIDS. Dr. Walensky is also a well-respected expert on the value of testing and treatment of deadly viruses.

Dr. Walensky served as Chief of the Division of Infectious Diseases at Massachusetts General Hospital from 2017-2020 and Professor of Medicine at Harvard Medical School from 2012-2020. She served on the frontline of the COVID-19 pandemic and conducted research on vaccine delivery and strategies to reach underserved communities.

Dr. Walensky is recognized internationally for her work to improve HIV screening and care in South Africa and nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings.

She is a past Chair of the Office of AIDS Research Advisory Council at the National Institutes of Health, Chair-elect of the HIV Medical Association, and previously served as an advisor to both the World Health Organization and the Joint United Nations Programme on HIV/AIDS.

Originally from Maryland, Dr. Walensky received her Bachelor of Arts from Washington University in St. Louis, her Doctor of Medicine from the Johns Hopkins School of Medicine, and her Masters in Public Health from the Harvard School of Public Health.

Chiquita Brooks-LaSure, MPP

Chiquita Brooks-LaSure is the Administrator for the Centers for Medicare and Medicaid Services (CMS), where she will oversee programs including Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the HealthCare.gov health insurance marketplace. 

A former policy official who played a key role in guiding the Affordable Care Act (ACA) through passage and implementation, Brooks-LaSure has decades of experience in the federal government, on Capitol Hill, and in the private sector. 

As deputy director for policy at the Center for Consumer Information and Insurance Oversight within the Centers for Medicare & Medicaid Services, and earlier at the Department of Health & Human Services as director of coverage policy, Brooks-LaSure led the agency’s implementation of ACA coverage and insurance reform policy provisions. 

Earlier in her career, Brooks-LaSure assisted House leaders in passing several health care laws, including the Medicare Improvements for Patients and Providers Act of 2008 and the ACA, as part of the Democratic staff for the U.S. House of Representatives’ Ways and Means Committee. 

Brooks-LaSure began her career as a program examiner and lead Medicaid analyst for the Office of Management and Budget, coordinating Medicaid policy development for the health financing branch. Her role included evaluating policy options and briefing White House and federal agency officials on policy recommendations with regard to the uninsured, Medicaid and the Children’s Health Insurance Program.

David J. Smith, MD

Dr. David J. Smith is the Deputy Assistant Secretary of Defense for Health Readiness Policy and Oversight. In this role he directs Department-wide efforts to develop and implement policies and programs relating to DOD deployment medicine, force health protection, national disaster support, medical research and development, international health agreements and missions, and medical readiness for 2.3 million Service members.

Prior to his present role, he performed the duties of the Reform Leader for Health Care Management as part of an overall improvement to the quality and productivity of the business operations of the Department, including using more enterprise services and reducing costs. Smith also served in the role of the Assistant Secretary of Defense for Health Affairs from February – August 2017, and acting Principal Deputy Secretary of Defense during September and October 2017.

Smith received a Bachelor of Science degree from the University of Illinois in 1977 and completed his Doctor of Medicine degree at Northwestern University Medical School in 1981. He completed his Occupational Medicine Training at the University of Cincinnati Medical School in 1989, where he received a Master of Science in Environmental Health. Smith is a certified physician executive (CPE), fellow of the American College of Occupational and Environmental Medicine (FACOEM) and is board certified in Occupational Medicine with a certificate of added qualification in Undersea Medicine. He also has a Certificate in Medical Management from the American College of Physician Executives at Tulane University.

After receiving his Master’s degree and completing his residency in Occupational and Environmental medicine, he served as the United States Navy medical exchange officer, Institute of Naval Medicine, Alverstoke, England. He then held positions as the head of the Safety and Health Department at the Armed Forces Radiobiology Research Institute; occupational health consultant for the Defense Nuclear Agency; Director of Occupational and Community Health at National Naval Medical Center, and Commanding Officer, Naval Hospital Rota, Spain.

In July 2003, Smith accepted the appointment as chief of staff, TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs). Smith helped lead the migration to the new TRICARE contracts, expanded the Reserve Health Benefit, and implemented new regional governance. Afterwards, he served as the Deputy Chief for Health Care Operations (M3) at the Bureau of Medicine and Surgery and became chief of Operations in June 2005, responsible for all Navy peacetime and deployed medical operations.

In May 2008, Smith became the Joint Staff Surgeon where he served as the chief medical advisor to the Chairman of the Joint Chiefs of Staff, providing counsel to the chairman, the joint staff, and combatant commanders. In October 2010, Smith deployed as the International Security Assistance Force-Afghanistan (ISAF) medical advisor and Chief, Joint Medical overseeing medical care and health development for the Afghan theater of operations. Prior to retiring from the Navy as a Rear Admiral, upper half, in October 2012, he was Director, Medical Resources, Plans and Policy Division on the Chief of Naval Operations staff where he developed and evaluated plans and policy for medical support to current and future Navy and Marine Corps operations.

Rachel Levine, MD, FAAP

Dr. Rachel L. Levine serves as the 17th Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS), after being nominated by President Joe Biden and confirmed by the U.S. Senate in 2021. As Assistant Secretary for Health, Dr. Rachel Levine fights every day to improve the health and well-being of all Americans. She’s working to help our nation overcome the COVID-19 pandemic and build a stronger foundation for a healthier future – one in which every American can attain their full health potential.

After graduating from Harvard College and Tulane University School of Medicine, Dr. Levine completed her training in Pediatrics and Adolescent Medicine at the Mt. Sinai Medical Center in New York City. As a physician, she focused on the intersection between mental and physical health, often treating children, adolescents, and young adults. Dr. Levine was a Professor of Pediatrics and Psychiatry at the Penn State College of Medicine. Her previous posts included: Vice-Chair for Clinical Affairs for the Department of Pediatrics, and Chief of the Division of Adolescent Medicine and Eating Disorders at the Penn State Hershey Medical Center.

In 2015, Pennsylvania Governor Tom Wolf nominated Dr. Levine to be Pennsylvania’s Physician General and she was subsequently unanimously confirmed by Pennsylvania’s state Senate. In March of 2018, Dr. Levine was named Pennsylvania’s Secretary of Health. During her time in state government, Dr. Levine worked to address Pennsylvania’s opioid crisis, focus attention on maternal health and improve immunization rates among children. Her decision to issue a standing order for the anti-overdose drug, Naloxone, saved thousands of lives by allowing law enforcement to carry the drug and Pennsylvanians to purchase it without a prescription from their doctor

Dr. Levine is a Fellow of the American Academy of Pediatrics, the Society for Adolescent Health and Medicine, and the Academy for Eating Disorders. She was also the President of the Association of State and Territorial Health Officials. In addition to her recent posts in medicine and government, Dr. Levine is an accomplished speaker and author of numerous publications on the opioid crisis, adolescent medicine, eating disorders, and LGBT medicine.

Steven L. Lieberman, MD, MBA, FACHE, FACP

Steven L. Lieberman, MD, MBA, FACHE, FACP, is the Deputy Under Secretary for Health Performing the Delegable Duties of the Under Secretary for Health. He leads the Veterans Health Administration (VHA), the largest integrated health system in the nation, managing a budget of over $87 billion and overseeing the care of 9 million Veterans.

Most recently, Dr. Lieberman served as Acting Deputy Under Secretary for Health in the Department of Veterans Affairs, leading clinical policies and programs and helping guide VHA through the coronavirus pandemic. Prior to that role, as Assistant Deputy Under Secretary for Health for Access to Care, Dr. Lieberman provided executive leadership, strategic direction, and oversight for the transformation of Veteran access to health care within VHA. He was responsible for operational policies regarding clinic management related to access, scheduling, consult management, and wait times.

Dr. Lieberman has over 25 years’ experience with VHA as a board-certified physician in Pulmonary and Critical Care Medicine as well as leadership roles including Associate Chief of Staff for Quality Management and Deputy Chief of Staff at VA Boston Health Care System and Chief of Staff at VA NJ Health Care System. He earned his medical degree from Rutgers New Jersey Medical School in Newark, NJ, underwent a residency in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia, PA, and completed his Fellowship in Pulmonary, Critical Care and Spinal Cord Injury Medicine at Harvard University Hospitals in Boston, MA. Dr. Lieberman also obtained an executive MBA from the Stern School of Business at New York University.

Accomplishments during his career include overseeing the integration of two VA Health care facilities into the current VA Boston Health Care System and serving as a Chief of Staff for VA-led Medical Federal Medical Station Missions following Hurricanes Rita and Gustave. He also served as Co-Chair of the national MyVA Access Sequester Team. Dr. Lieberman is a Fellow in the American College of Healthcare Executives where he additionally has served as a member of the VA Regent’s Advisory Council and the Physician Executives Forum Committee.

Robert M. Califf, MD

Robert M. Califf, MD, is Commissioner of Food and Drugs. President Joe Biden nominated Dr. Califf to head the U.S. Food and Drug Administration and Dr. Califf was sworn in on February 17, 2022. Previously, Dr. Califf served as Commissioner of Food and Drugs from February 2016 to January 2017. As the top official of the FDA, Dr. Califf is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. Dr. Califf served as the FDA’s Deputy Commissioner for Medical Products and Tobacco from February 2015 until his first appointment as Commissioner in February 2016.

Prior to rejoining the FDA, Dr. Califf was head of medical strategy and Senior Advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries Verily Life Sciences and Google Health. He joined Alphabet in 2019, after serving as a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,300 publications in the peer-reviewed literature.

Dr. Califf became a Member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, one of the highest honors in the fields of health and medicine. Dr. Califf has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and the FDA Science Board’s Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

While at Duke, Dr. Califf led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke’s Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory Coordinating Center.

Dr. Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

Carole Johnson, MD

Johnson joined HRSA from the White House COVID-19 Response Team. She previously served as Commissioner of the New Jersey Department of Human Services, leading the state’s largest agency and providing health care and social services to one-in-five New Jerseyans. During her tenure as Commissioner, the Department expanded Medicaid coverage of mental health and substance use disorder services, created new Medicaid benefits to improve maternal health outcomes, and integrated Medicaid into the newly launched state-based Affordable Care Act marketplace. Under Johnson’s leadership, the Department also substantially increased child care rates for the first time in a decade, expanded food assistance benefits, and created an Office of New Americans to support the state’s diverse communities.

Johnson served for more than five years as the Domestic Policy Council public health lead in the Obama White House, working on the Ebola and Zika responses, implementation of the Affordable Care Act, and combatting the opioid epidemic. In addition, she served on Capitol Hill as health staff for the U.S. Senate Special Committee on Aging and for members of the U.S. Senate Finance Committee and U.S. House of Representatives Ways and Means Committee.

At the Department of Health and Human Services, Johnson previously managed health care workforce policy issues for HRSA. She also was policy director for the Alliance of Community Health Plans, program officer with the Pew Charitable Trusts health program, and senior government relations manager with the American Heart Association.

She holds a master’s degree in government from the University of Virginia.

Lawrence A. Tabak, DDS, PhD

Lawrence A. Tabak, DDS, PhD, is the Acting Director of the National Institutes of Health (NIH), officially taking office on December 20, 2021. Dr. Tabak has served as the Principal Deputy Director and the Deputy Ethics Counselor of NIH since August 2010. He previously served as the Acting Principal Deputy Director of NIH (2009), and prior to that as Director of the National Institute of Dental and Craniofacial Research from 2000–10.

Prior to joining NIH, Dr. Tabak was the Senior Associate Dean for Research and Professor of Dentistry and Biochemistry & Biophysics in the School of Medicine and Dentistry at the University of Rochester in New York. A former NIH MERIT recipient, Dr. Tabak’s major research focus has been on the structure, biosynthesis, and function of glycoproteins. He continues work in this area, maintaining an active research laboratory within the NIH intramural program in addition to his administrative duties.

Dr. Tabak is an elected member the National Academy of Medicine (formerly IOM) of the National Academies. He received his undergraduate degree from City College of New York, his D.D.S. from Columbia University, and a Ph.D. from the University of Buffalo.

Micky Tripathi, PhD. MPP

Micky Tripathi is the National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, where he leads the formulation of the federal health IT strategy and coordinates federal health IT policies, standards, programs, and investments. 

Mr. Tripathi has over 20 years of experience across the health IT landscape. He most recently served as Chief Alliance Officer for Arcadia, a health care data and software company focused on population health management and value-based care, the project manager of the Argonaut Project, an industry collaboration to accelerate the adoption of FHIR, and a board member of HL7, the Sequoia Project, the CommonWell Health Alliance, and the CARIN Alliance.

Mr. Tripathi served as the President and Chief Executive Officer of the Massachusetts eHealth Collaborative (MAeHC), a non-profit health IT advisory and clinical data analytics company. He was also the founding President and CEO of the Indiana Health Information Exchange, a statewide HIE partnered with the Regenstrief Institute, an Executive Advisor to investment firm LRVHealth, and a Fellow at the Berkman-Klein Center for Internet and Society at Harvard University.

He holds a PhD in political science from the Massachusetts Institute of Technology, a Master of Public Policy from Harvard University, and an AB in political science from Vassar College. Prior to receiving his PhD, he was a Presidential Management Fellow and a senior operations research analyst in the Office of the Secretary of Defense in Washington, DC, for which he received the Secretary of Defense Meritorious Civilian Service Medal.


Join Our Community

Sign up for NAM email updates